Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode
XIAP/蛋白酶体通路的靶向治疗通过将凋亡信号转换为 Bax/Bak 独立的“I 型”模式来克服癌症中的 TRAIL 抗性
期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/cddis.2013.67
B Gillissen, A Richter, A Richter, T Overkamp, F Essmann, P G Hemmati, R Preissner, C Belka, P T Daniel
